Doebele R, et al. Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). IASLC 2018; abstract OA02.01.
Poly (ADP-ribose) polymerase (PARP-)remmers bij het ovariumcarcinoom
sep 2018 | Gynaecologische oncologie